comparemela.com

Page 3 - Pfizer Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon

On 23 June 2021 at its Investor Update, GSK plc (“GSK” or the “Company”) confirmed its intention to separate its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. It is proposed that the separation will be effected by way of a demerger (the “Demerger”) of .

Q&A: enforcement of dominance rules in Indonesia

£251m in de-risking deals as AIB converts APP, Wyeth seals buy-in

Pfizer affiliate vaccinates U K plan with second buy-in

Pfizer affiliate vaccinates U.K. plan with second buy-in BLOOMBERG Wyeth Group Pension and Life Assurance Scheme (1997), Sheffield, England, completed a £190 million ($268 million) buy-in with Aviva, confirmed Suthan Rajagopalan, risk transfer partner at Mercer. Mercer acted on behalf of the pension plan trustees. The deal covers just less than 50% of total liabilities. The £450 million pension fund, which is sponsored by Pfizer Group affiliate John Wyeth & Brother, has now insured close to all defined benefit liabilities through the latest buy-in and a £158 million risk transfer deal with Just Group in 2018, Mr. Rajagopalan said in an email. This is another important step for the scheme and wider group as we seek to secure members benefits and reduce the risk exposures of our pension arrangements, Patrick McKenna, senior director international pensions at Pfizer, said in a news release by Aviva. Aviva put forward attractive pricing and innovation proposals to address a c

Pfizer in talks with India over expedited approval for COVID-19 vaccine: CEO

ANI | Updated: May 03, 2021 14:38 IST New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an expedited approval pathway for its COVID-19vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India. Unfortunately, our vaccine is not registered in India although our application was submitted months ago, Bourla, in a LinkedIn post, on Monday. We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country. Pfizer group is committed to being a partner in India s fight against this disease and is quickly working to mobilize the largest humanitarian relief effort in our company s history, he added.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.